Literature DB >> 2307791

Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy.

P Spirito1, B J Maron.   

Abstract

In hypertrophic cardiomyopathy, the relation between left ventricular diastolic impairment and magnitude of left ventricular hypertrophy has not been clearly defined. In the present study, Doppler echocardiographic indexes of left ventricular diastolic filling were compared in 78 patients with hypertrophic cardiomyopathy and in 72 normal control subjects of similar age, and the relation between abnormalities of diastolic filling and magnitude of left ventricular hypertrophy was assessed. In patients with hypertrophic cardiomyopathy, isovolumic relaxation was prolonged (94 +/- 25 ms); peak early diastolic flow velocity (53 +/- 18 cm/s), deceleration of flow velocity in early diastole (341 +/- 142 cm/s2) and the ratio between early and late peaks of flow velocity (1.6 +/- 0.9) were reduced; and peak late diastolic flow velocity was increased (38 +/- 15 cm/s) compared with values in control subjects (76 +/- 12 ms, 65 +/- 12 cm/s, 512 +/- 131 cm/s2, 2.3 +/- 0.8 and 30 +/- 7 cm/s, respectively; p less than 0.001). Individual patient analysis showed that diastolic filling was abnormal in 52 (67%) of the 78 patients with hypertrophic cardiomyopathy. However, within the patient group, none of the Doppler diastolic indexes showed a significant correlation with maximal left ventricular wall thickness or the wall thickness index (correlation coefficients ranged from -0.15 to 0.10).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2307791     DOI: 10.1016/0735-1097(90)90278-w

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

1.  Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries: effect of beta adrenergic blockade.

Authors:  G Fragasso; S L Chierchia; G Pizzetti; E Rossetti; M Carlino; S Gerosa; O Carandente; A Fedele; N Cattaneo
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

2.  Benazepril and subclinical feline hypertrophic cardiomyopathy: a prospective, blinded, controlled study.

Authors:  Mylène Taillefer; Rocky Di Fruscia
Journal:  Can Vet J       Date:  2006-05       Impact factor: 1.008

3.  Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity.

Authors:  Y Matsumura; P M Elliott; M S Virdee; P Sorajja; Y Doi; W J McKenna
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

4.  Cardiac tissue Doppler imaging in sports medicine.

Authors:  Anne Krieg; Jürgen Scharhag; Wilfried Kindermann; Axel Urhausen
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

5.  Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.

Authors:  P Richard; R Isnard; L Carrier; O Dubourg; Y Donatien; B Mathieu; G Bonne; F Gary; P Charron; M Hagege; M Komajda; K Schwartz; B Hainque
Journal:  J Med Genet       Date:  1999-07       Impact factor: 6.318

Review 6.  Thin filament mutations: developing an integrative approach to a complex disorder.

Authors:  Jil C Tardiff
Journal:  Circ Res       Date:  2011-03-18       Impact factor: 17.367

7.  Relaxation in hypertrophic cardiomyopathy and hypertensive heart disease: relations between hypertrophy and diastolic function.

Authors:  S F De Marchi; Y Allemann; C Seiler
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

Review 8.  Left ventricular diastolic function: physiology, methods of assessment, and clinical significance.

Authors:  J A Arrighi; R Soufer
Journal:  J Nucl Cardiol       Date:  1995 Nov-Dec       Impact factor: 5.952

9.  Echocardiographic characterization of hypertrophic cardiomyopathy in Chinese patients with myosin-binding protein C3 mutations.

Authors:  Bei Zhao; Shouli Wang; Jinsong Chen; Yali Ji; Jing Wang; Xiaoli Tian; Guang Zhi
Journal:  Exp Ther Med       Date:  2017-01-25       Impact factor: 2.447

10.  Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy.

Authors:  Sung-A Chang; Sang-Chol Lee; Yeon Hyeon Choe; Hye-Jin Hahn; Shin Yi Jang; Sung-Ji Park; Jin-Oh Choi; Seung Woo Park; Jae K Oh
Journal:  Int J Cardiovasc Imaging       Date:  2012-10-25       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.